Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 1 to 5 of 5

Sort by

Last updated date between: 1/11/2017 and 30/11/2017Remove Last updated date between: 1/11/2017 and 30/11/2017 filter
Type: GuidanceRemove Type: Guidance filter
Type: NICE adviceRemove Type: NICE advice filter
Type: Quality standardRemove Type: Quality standard filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Clinical guidelinesRemove Guidance programme: Clinical guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter
Guidance programme: Social care guidelinesRemove Guidance programme: Social care guidelines filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Vismodegib for treating basal cell carcinoma	TA489	22 November 2017	22 November 2017
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane	TA458	19 July 2017	20 November 2017
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours	TA488	15 November 2017	15 November 2017
Aflibercept for treating choroidal neovascularisation	TA486	1 November 2017	1 November 2017
Sarilumab for moderate to severe rheumatoid arthritis	TA485	1 November 2017	1 November 2017

Results per page

10
25
50
All